Capricor Therapeutics, Inc.

CAPRNASDAQHealthcare● Active

$26.16

$-0.55(-2.06%)

Market Cap$1.2B

P/E Ratio—

52W High$40.37

52W Low$4.3

Avg Volume1.2M

Open$27.15

Beta0.37

Net Income Financials Revenue

Capricor Therapeutics, Inc. (CAPR) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CAPR · net income · updated Jun 9, 2026

Core profitability metrics

CAPR · net income · margin · TTM · CAGR

Net income was −$105.0M for FY2025 (fiscal year ending 2025-12-31), down 159.6% year-over-year. Net profit margin was —. Based on available data, Capricor Therapeutics, Inc. has been profitable since at least 2017.

FY2025 Net Income−$105.0M▼ -159.6% YoY

Trailing 12M (TTM)−$114.6Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-159.6%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2017

▸ FMP /income-statement · Annual · CAPR net income history · CAPR profit margin

Annual net income data

CAPR · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$105.0M▼ 159.6%—$0

FY2024Loss−$40.5M▼ 81.6%-181.7%$22.3M

FY2023Loss−$22.3M▲ +23.2%-88.5%$25.2M

FY2022Loss−$29.0M▼ 44.9%-1137.4%$2.6M

FY2021Loss−$20.0M▼ 46.6%-8175.9%$244,898

Net income vs peers (Healthcare)

CAPR vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Capricor Therapeutics, Inc.YOU

CAPR

−$105.0M-159.6%—

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Capricor Therapeutics, Inc. (CAPR) reported net income of −$105.0M for FY2025 (fiscal year ending 2025-12-31), down 159.6% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Capricor Therapeutics, Inc. has been profitable since at least 2017. Net income reached a peak of $2.4M in FY2017. Data available for 15 fiscal years.

Capricor Therapeutics, Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Capricor Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from CAPR net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CAPR net income · 4 questions

Capricor Therapeutics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $105.0M for FY2025.

is CAPR profitabledoes CAPR make a profitCAPR profitabilityCAPR profitable company

▸ Source: FMP /income-statement · GAAP · Capricor Therapeutics, Inc. · Capricor Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026